AHA responds to the RFI on the drivers of health care workforce shortages and solutions.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA comments on the Request for Information on the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
AHA Comments on the Advancing Interoperability and Improving Prior Authorization Processes Proposed Rule
AHA comments on the Centers for Medicare & Medicaid Services’ initial guidance regarding certain Inflation Reduction Act requirements.
Hospitals and health systems are committed to empowering patients with all the information they need to live their healthiest lives. This includes ensuring they have access to accurate price information when seeking care. Our members are working to comply with both state and federal price transparency policies, which include the federal Hospital Price Transparency Rule and provisions in the No Surprises Act.
AHA, hospital organizations asks Congress to address the Medicaid disproportionate share hospital (DSH) cuts scheduled to begin in fiscal year (FY) 2024 to ensure patients continue to have access to quality care.
AHA appreciates the opportunity to comment on the Department of Health and Human Services’ proposed rule regarding statutory conscience protections.
AHA letter to Representative Troy Balderson expressing support of H.R. 1110, the Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act.
The AHA opposes the Federal Trade Commission’s (FTC) proposed Non-Compete Clause Rule in its current form.
AHA shares comments on two topics that were discussed during the January 2023 public meeting: Medicare Part B drug payments and telehealth services.